This week is "UN Week" which marks the annual United Nations General Assembly meeting in New York. Top leaders from around the world have descended upon NY to discuss many pressing issues on the global agenda, including the SDG goals and improving health worldwide.
With an estimated 37 million people currently living with HIV globally and 2.1 million people becoming newly infected each year, Johnson & Johnson stands united with the global community to fight HIV and care for those infected, and impacted.
Johnson & Johnson issued a call for innovative ideas to reduce HIV infections in adolescent girls and young women in 10 sub-Saharan African countries as part of the DREAMS Innovation Challenge, supported by PEPFAR.
Johnson & Johnson announced it has joined more than 80 companies and organizations in signing the Declaration on Combating Antimicrobial Resistance, an industry-wide call to action that outlines how industry and governments can work together to support sustained innovation to address this growing problem.
Janssen and USAID entered into a new Memorandum of Understanding, as part of the U.S Government’s National Action Plan for combatting multi-drug resistant tuberculosis (MDR-TB), agreeing to expand patient access to novel MDR-TB therapies and increase funding for program partners.
Johnson & Johnson Vice President of Innovation, Global Public Health and Science Policy Communication, Seema Kumar shares her key highlights from the Global Fund Replenishment Conference to Fight HIV, Tuberculosis and Malaria.
Mental Health Now, or mhNOW, a new initiative founded by Global Development Incubator, Johnson & Johnson, Grand Challenges Canada, BasicNeeds, and StrongMinds, will help identify mental health solutions on a global scale.